NR3C2 and prostate cancer: As an example of genes with MR and colocalization evidence on two cancer sites, MAP2K1 in cell type TN at resting (0 h) showed colocalization evidence on prostate cancer and breast cancer (colocalization probability PP.H4 = 94% and 93% respectively; Figure 2B).